Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 59.88% | 66.18% | 62.70% | 53.40% | 51.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.88% | 66.18% | 62.70% | 53.40% | 51.55% |
| Cost of Revenue | 28.07% | 34.96% | 36.32% | 25.46% | 22.58% |
| Gross Profit | 97.70% | 105.45% | 97.13% | 95.95% | 110.74% |
| SG&A Expenses | 43.38% | -2.11% | 79.45% | 78.52% | 75.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.24% | 3.88% | 66.20% | 60.50% | 54.58% |
| Operating Income | -30.40% | 18.39% | -68.75% | -65.96% | -56.68% |
| Income Before Tax | -70.73% | 24.24% | -56.99% | -58.89% | -26.96% |
| Income Tax Expenses | 51.52% | 88.24% | 94.44% | 325.00% | 371.43% |
| Earnings from Continuing Operations | -70.71% | 24.02% | -57.02% | -58.99% | -27.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.71% | 25.39% | -58.85% | -60.96% | -29.88% |
| EBIT | -30.40% | 18.39% | -68.75% | -65.96% | -56.68% |
| EBITDA | -30.33% | 20.18% | -75.18% | -70.18% | -67.23% |
| EPS Basic | -49.54% | 70.46% | 51.01% | 46.44% | 55.05% |
| Normalized Basic EPS | -28.17% | 69.02% | 43.05% | 37.27% | 49.03% |
| EPS Diluted | -49.54% | 70.46% | 51.01% | 46.44% | 55.05% |
| Normalized Diluted EPS | -28.17% | 69.02% | 43.05% | 37.27% | 49.03% |
| Average Basic Shares Outstanding | 14.15% | 137.54% | 180.85% | 158.36% | 158.00% |
| Average Diluted Shares Outstanding | 14.15% | 137.54% | 180.85% | 158.36% | 158.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |